Clinical Trial Update: Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial evaluating immediate versus delayed febuxostat treatment for gout. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• FEBUXOSTAT (Febuxostat)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Gout | Phase 3 | Status: RECRUITING